Observational Study to Assess Migraine Prediction Tool

SuspendedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2030

Primary Completion Date

October 1, 2030

Study Completion Date

November 15, 2030

Conditions
Migraine
Interventions
OTHER

Daily questionnaire

All patients will be asked to complete a daily questionnaire regarding their migraine, medications, and prodromal symptoms during that day

Trial Locations (3)

12601

Nuvance Health Vassar Medical Center, Poughkeepsie

39157

Headache Neurology Research Institute, Ridgeland

06880

Westport Headache Institute, Westport

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT05523310 - Observational Study to Assess Migraine Prediction Tool | Biotech Hunter | Biotech Hunter